These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3873951)

  • 1. [In vitro synthesis of interleukin 2 (IL-2) by T lymphocytes extracted from a lymphoepithelial thymoma. Purification and biochemical characterization].
    Ponzoni M; Fenice M; Montaldo P; Tonini GP; Cornaglia-Ferraris P
    Boll Ist Sieroter Milan; 1985; 64(1):12-24. PubMed ID: 3873951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cells from lymphoepithelial thymoma produce a biochemical variant of IL-2.
    Cornaglia-Ferraris P; Ponzoni M
    Lymphokine Res; 1985; 4(3):251-63. PubMed ID: 3875768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells.
    Brown WC; Grab DJ
    J Immunol; 1985 Nov; 135(5):3184-90. PubMed ID: 3930599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymoma production of T cell growth factor (Interleukin 2).
    Farrar JJ; Fuller-Farrar J; Simon PL; Hilfiker ML; Stadler BM; Farrar WL
    J Immunol; 1980 Dec; 125(6):2555-8. PubMed ID: 6968789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-lymphocyte progenitors in man: biochemical characterization of a colony promoting activity (CPA) active on immature precursors.
    Triebel F; Gluckman JC; Debre P; Charron DJ
    Immunology; 1984 Dec; 53(4):651-7. PubMed ID: 6334017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive production by the WEHI-3 cell line of B cell growth and differentiation factor that co-purifies with interleukin 1.
    Booth RJ; Prestidge RL; Watson JD
    J Immunol; 1983 Sep; 131(3):1289-93. PubMed ID: 6604093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and biologic characterization of lymphocyte regulatory molecules. IV. Purification of Interleukin 2 from a murine T cell lymphoma.
    Mochizuki D; Watson J; Gillis S
    J Immunol; 1980 Dec; 125(6):2579-83. PubMed ID: 7000903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
    Gillis S; Scheid M; Watson J
    J Immunol; 1980 Dec; 125(6):2570-8. PubMed ID: 6968790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No Shinkei Geka; 1984 Feb; 12(2):141-50. PubMed ID: 6609319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.
    Schwyzer M; Fontana A
    J Immunol; 1985 Feb; 134(2):1003-9. PubMed ID: 3871205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of human interleukin 2 produced from normal human peripheral blood mononuclear cells.
    Kermani-Arab V; Uittenbogaart C; Bramhall J
    Thymus; 1986; 8(1-2):3-11. PubMed ID: 3487853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The purification and properties of human T cell growth factor.
    Mier JW; Gallo RC
    J Immunol; 1982 Mar; 128(3):1122-7. PubMed ID: 6976987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant EL-4 thymoma cells polyclonally activate murine and human B cells via direct cell interaction.
    Zubler RH; Erard F; Lees RK; Van Laer M; Mingari C; Moretta L; MacDonald HR
    J Immunol; 1985 Jun; 134(6):3662-8. PubMed ID: 3886789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A biochemical variant of human T cell growth factor produced by a cutaneous T cell lymphoma cell line.
    Gootenberg JE; Ruscetti FW; Gallo RC
    J Immunol; 1982 Oct; 129(4):1499-505. PubMed ID: 6980938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
    Rubin LA; Kurman CC; Fritz ME; Biddison WE; Boutin B; Yarchoan R; Nelson DL
    J Immunol; 1985 Nov; 135(5):3172-7. PubMed ID: 3930598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.